Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma...

Area of Science:

• Neuroscience
• Biomarkers
• Medical Prognostics

Background:

• Mild cognitive impairment (MCI) significantly increases the risk of developing Alzheimer's disease (AD) dementia.
• Accurate prediction of MCI-to-dementia progression is crucial for timely intervention and clinical trial design.

Purpose of the Study:

• To develop and validate a multivariate prognostic model for predicting individual MCI-to-dementia progression.
• To identify key predictors of progression using a comprehensive dataset.

Main Methods:

• A probabilistic, kernel-based pattern classification approach was used with baseline data from 259 MCI patients.
• Over 750 variables from risk factors, cognitive/functional assessments, MRI, and plasma proteomics were analyzed.
• A rigorous cross-validation framework assessed predictive utility for progression over a three-year follow-up.

Main Results:

• Cognitive, functional, and morphometric MRI markers were most predictive of progression.
• The best model achieved 80% accuracy (83% sensitivity, 76% specificity, AUC = 0.87) in predicting progression.
• Key predictors included specific cognitive test scores and brain region volumes/cortical thickness.

Conclusions:

• An accurate, multivariate prognostic model for MCI-to-dementia progression was developed.
• The model uses cost-effective, non-invasive markers, enhancing its clinical applicability.
• This tool can improve patient selection for clinical trials and identify high-risk MCI individuals for early treatment.